On ECHEMI
Home > Drugs > Acute heterozygous leukemia
Acute heterozygous leukemia
Acute hybrid leukemia (HAL), also known as acute mixed cell leukemia, is an acute leukemia in which both myeloid cell lineage and lymphocyte lineage are affected and reach a certain score.
  • Site of disease:

    Bone marrow lymphatic blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    Lymph node enlargement hepatosplenomegaly anemia increased intracranial pressure lung infection
  • Concurrent disease:

Related Drugs
Cytarabine Hydrochloride for Injection
Indication: It is suitable for the induction remission and maintenance consolidation phases of acute leukemia. It has a better effect on acute non-lymphocytic leukemia, the blast crisis phase of chronic myeloid leukemia, and malignant lymphoma.
Manufacturer:

Han Hui Pharmaceuticals Company Limited

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.